Skip to content

Researcher Stories

Get to know the PhRMA Foundation’s award recipients.

Missing ALT Text

Empowering Older Adults with Diabetes to Discuss Deprescribing with Doctors

Nha Tran, a PhD student at the University of Michigan, is studying what motivates or stops older adults with diabetes from talking with their clinicians about taking fewer medications.

Watch Now
Missing ALT Text

Reprogramming CAR T Cells to Overcome Barriers in Treating Solid Tumor Cancers

Azlann Arnett, a PhD student at the Baylor College of Medicine, is working to make CAR T cell therapy effective for solid cancer tumors.

Watch Now
Missing ALT Text

Learning From Psychedelics to Create Better Drug Targets

Michael Hsiao, a PhD student at the University of California, Berkley, received a 2024 PhRMA Foundation Predoctoral Fellowship in Drug Discovery.

Read More

Uncovering Early Molecular Changes in Parkinson’s Disease

Daichi Shonai, a PhD student at Duke University, is investigating the early molecular changes that occur within nerve cells during Parkinson’s disease. He hopes to identify early warning signs of the disease.

Awardee Spotlight

Audrey Brown, PhD

  • University of Virginia

“I am honored to have been chosen for the PhRMA Foundation Postdoctoral Fellowship in Translational Medicine. Using this fellowship, I will dedicate years of research toward understanding how genetic polymorphisms affect pathogen susceptibility, thereby building the foundation for preventions and treatments of deadly infectious diseases. ”

Exploring a New Drug Target for Treatment-Resistant Prostate Cancer

Prostate cancer is one of the most frequently diagnosed cancers, and hormone therapy to reduce levels of male androgen hormones works well as a treatment for most patients. However, many will relapse with treatment-resistant prostate cancer, where tumor growth continues despite exceptionally low levels of androgens. Min-Yu Ko, a PhD student at Duke University, is studying how low levels of androgens facilitate activation of specific protein, resulting in increased tumor growth.

PhRMA Foundation
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.